Enterprise Value
-27.41M
Cash
90.48M
Avg Qtr Burn
-12.62M
Short % of Float
0.59%
Insider Ownership
0.00%
Institutional Own.
0.00%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
AVR-RD-05 Details Mucopolysaccharidoses, Mucopolysaccharidosis type II, Rare diseases, Rare genetic disease, Genetic disorder | Failed Discontinued | |
AVR-RD-04 Details Cystinosis | Failed Discontinued | |
AVR-RD-02 Details Gaucher disease | Failed Discontinued | |
AVR-RD-01 Details Genetic disorder, Fabry disease | Failed Discontinued |